Search

everythinglearnresearchcommunity

for

Search:↓

Animal models are crucial for learning about hair loss and finding treatments.

The document concludes that oral finasteride and topical minoxidil are effective for genetic hair loss, while other treatments for different types of hair loss show promise but need more research.

Minoxidil effectively treats hair loss, especially androgenetic alopecia, but needs more research for better understanding.

Leptin affects skin and hair health and may worsen some skin conditions, but more research is needed to understand its full impact.

Ruxolitinib may help treat hair loss by reducing inflammation, promoting hair growth signals, and protecting hair follicle immunity.

People with Lichen Planopilaris tend to be more depressed, have lower self-esteem, and a worse quality of life.

Plant-based remedies may treat hair loss by reducing inflammation and improving insulin resistance.

A patient with complete hair loss regrew all her hair using tofacitinib.

New treatments and early diagnosis methods for permanent hair loss due to scar tissue are important for managing its psychological effects.

Alopecia areata has a complex genetic basis that was not fully understood as of 2001.

Tofacitinib nanoparticles can safely and effectively treat alopecia areata by targeting hair follicles.

Platelet-Rich Plasma (PRP) could potentially help regrow hair in people with Alopecia Areata, but more research is needed to confirm its effectiveness.

Lupus treatment requires a combination of drugs and therapies, with research needed for new options.

HIV-1 may cause increased stem cell death in hair follicles, leading to hair loss.

A combination of oral cyclosporin and PUVA treatment worked well for a severe skin condition called generalized pustular psoriasis.

Baricitinib shows promise as a new treatment for certain skin conditions like alopecia areata.

SARS-CoV-2, the virus causing COVID-19, can affect all endocrine organs and systems, altering their function and potentially leading to disorders. Factors like diabetes and obesity increase infection risk and severity. Understanding these effects is key for effective treatment.

Umbilical cord cells safely improve healing in long-term nonhealing wounds better than a placebo.

Tofacitinib, an arthritis drug, helped hair growth in alopecia universalis but long-term safety needs more research.

Two compounds from Asiasarum heterotropoides roots show potential as lung cancer treatments without harming normal cells.

The cause of alopecia areata was unknown, and while various treatments existed, no best treatment was agreed upon.

Botulinum toxin's effectiveness for treating scalp alopecia is not well-supported due to insufficient data.

The document concludes that a new system using the SALT score should replace the current alopecia areata classification for better accuracy in assessing severity and prognosis.

Adipose tissue shows promise for hair regrowth, but more research is needed to confirm best practices and effectiveness.

The document concludes that diagnosing and treating hair loss is complex and requires understanding its psychological effects and underlying causes, while also calling for more research and new treatments.

The document concludes that recognizing specific histological features of different nonscarring alopecias is crucial for accurate diagnosis and understanding hair loss progression.

Common types of non-scarring hair loss have various causes and treatments, but more effective solutions are needed.

Inflammation and Demodex mites might contribute to hair loss, and targeting them could help treat it.

JAK inhibitors effectively improve hair regrowth in alopecia areata with an acceptable safety profile.

Increasing PBX1 reduces aging and cell death in hair follicle stem cells by boosting SIRT1 and lowering PARP1 activity.